Form 4: Inspire Medical Systems CFO Richard Buchholz Reports Stock Sale

Richard Buchholz, CFO of Inspire Medical Systems, reported the sale of 15,000 shares of common stock on April 17, 2024, according to a Form 4 filing with the SEC.

Summary

• On April 17, 2024, Richard Buchholz, the CFO of Inspire Medical Systems, sold 15,000 shares of common stock at a weighted average price of $230.03.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 31, 2023.
• Following the transaction, Buchholz directly owns 28,271 shares and indirectly owns 5,400 shares through his children.
• The indirect ownership is split equally among four children, each holding 1,350 shares.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transaction was pre-planned under a Rule 10b5-1 trading plan. It doesn't necessarily reflect a positive or negative outlook on the company's future performance.

Industry Context

Insider sales are a common occurrence and are often viewed in the context of pre-planned trading programs. The market typically assesses the size and frequency of such sales to gauge potential impact.

Stakeholder Impact

• The stock sale could have a minor impact on shareholder sentiment, depending on how the market interprets the transaction.

Key Dates